Je was op zoek naar: dextromethorphan (Engels - Deens)

dextromethorphan
dextromethorphan

amantadine, ketamine, dextromethorphan
amantadin, ketamin, dextromethorfan

dextromethorphan (cyp2d6 substrate)
dextromethorphan (cyp2d6-substrat)

dextromethorphan acts on the brain.
dextromethorphan virker på hjernen.

dextromethorphan (inn) and its salts
dextromethorphan (inn) og salte deraf

dextromethorphan (inn) and its salts
dextromethorphan (inn) og salte deraf

dextromethorphan: no dose adjustment required.
dextromethorphan: justering af dosis ikke nødvendig.

amantadine, ketamine, dextromethorphan dantrolene, baclofen
amantadin, ketamin, dextromethorfan dantrolen, baclofen

dextromethorphan (used as an antitussive in cough mixtures)
hostestillende medicin i hostesaft (dextromethorphan )

cold or cough remedies containing dextromethorphan, ephedrine or pseudoephedrine
lægemidler ved forkølelse eller hoste, der indeholder dextrometorfan, efedrin eller pseudoefedrin

- if you take medicines containing fluoxetine, fluvoxamine, dextromethorphan or
- hvis de samtidig tager medicin, der indeholder fluoxetin, fluvoxamin, dextrometorfan eller

however, cases of dextromethorphan abuse have been reported, predominately in adolescents.
misbrug af dextromethorphan er dog beskrevet, hovedsagelig hos unge.

dextromethorphan / quinidine has not been studied in patients with severe renal impairment.
dextromethorphan/kinidin er ikke undersøgt hos patienter med svært nedsat nyrefunktion.

the same may be true for ketamine and dextromethorphan (see also section 4.4).
det samme kan gøre sig gældende for ketamin og dextromethorfan (se også under punkt 4.4).

there have been reports of drug interactions with the concomitant use of dextromethorphan and non selective mao inhibitors.
lægemiddelinteraktion er observeret ved samtidig indtagelse af dextromethorfan og non- selektive mao hæmmere.

the exact mechanism by which dextromethorphan exerts therapeutic effects in patients with pseudobulbar affect is unknown.
den nøjagtige mekanisme bag dextromethorphans terapeutiske virkning hos patienter med pseudobulbær affekt kendes ikke.

in such um patients, dextromethorphan is rapidly metabolised, leading to lower, potentially subtherapeutic concentrations.
hos sådanne um-patienter metaboliseres dextromethorphan hurtigt, hvilket medfører lavere, potentielt subterapeutiske koncentrationer.

during celecoxib treatment, the mean plasma concentrations of the cyp2d6 substrate dextromethorphan were increased by 136%.
under behandling med celecoxib steg den gennemsnitlige plasmakoncentration af cyp2d6-substratet dextromethorphan med 136%.

dextromethorphan is rapidly metabolized by cyp2d6 to its primary metabolite, dextrorphan, which is rapidly glucuronidated and renally eliminated.
dextromethorphan metaboliseres hurtigt af cyp2d6 til den primære metabolit dextrorphan, der hurtigt glukuronideres og udskilles renalt.

dextromethorphan (generally used to treat cough) and other nmda-antagonists at the same time should be avoided.
dextromethorfan (anvendes generelt til behandling af hoste) og andre nmda-antagonister bør undgås.